Mumbai, June 02nd, 2026: Alembic Pharmaceuticals is pleased to announce the appointment of Mr. Ramesh Juneja as Executive Vice President – Human Health (Sales and Marketing), for its India business.
Mr. Juneja brings over three decades of distinguished experience in pharmaceutical sales and marketing, having successfully led large businesses across both acute and chronic therapy segments.
Over the course of his career, Mr. Juneja has held several key leadership positions at leading pharmaceutical organizations including Sun Pharmaceutical Industries and Cipla, where he was instrumental in driving business growth, market expansion, commercial execution, and building high performing teams across multiple therapy areas. During his tenure, he led large-scale sales and marketing functions and helped enhance organizational capabilities in highly competitive markets.
Commenting on the appointment, Mr. Shaunak Amin, Managing Director, Alembic Pharmaceuticals, said, “We are delighted to welcome Mr. Ramesh Juneja to the Alembic family. His extensive industry experience, strategic perspective, and proven leadership in building and scaling businesses make him a valuable addition to our leadership team. We are confident that his deep understanding of the pharmaceutical landscape and strong commercial acumen will play a significant role in strengthening our Human Health business and supporting Alembic’s continued growth journey.”
Prior to joining Alembic, Mr. Juneja founded the Ramesh Juneja Business Advisory and co-founded BJW Health Pvt. Ltd. He also served as Senior Vice President at Reliance Retail, where he led the pan India launch of Netmeds B2B business and Netmeds Express stores.
Mr. Juneja is a pharmacy graduate from Sant Gadge Baba Amravati University and holds an MBA from Symbiosis International University. He also has completed his Executive Development Programs at the Indian School of Business and the National University of Singapore.
The organization extends its warm wishes to Mr. Juneja and looks forward to his valuable contribution in driving the next phase of growth and excellence at Alembic Pharmaceuticals.
